Medication Noncompliance and Patient Satisfaction Following Percutaneous Coronary Intervention

被引:11
|
作者
Aghabekyan, Seda [1 ]
Thompson, Michael E. [2 ]
Abrahamyan, Lusine [3 ]
机构
[1] Amer Univ Armenia, Ctr Hlth Serv Res & Dev, Yerevan 0019, Armenia
[2] Univ N Carolina, Dept Publ Hlth Sci, Charlotte, NC 28223 USA
[3] Inst Clin Evaluat Sci, Toronto, ON, Canada
关键词
ADHERENCE; PREDICTORS; OUTCOMES; THERAPY; DISEASE;
D O I
10.1111/j.1540-8183.2012.00743.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: This study evaluated the relationship between medication noncompliance and patient satisfaction in patients with drug-eluting stent revascularization in Armenia. Background: Reasons for medication noncompliance are multifactorialoften related to health system, patient, condition, therapy, and socioeconomic factors. Methods: The analytical cross-sectional survey used a simple random sample of patients aged 18 and over who had undergone percutaneous coronary artery intervention with drug-eluting stent from 2006 to 2008 (n = 271) at Nork Marash Medical Center, Yerevan, Armenia. Medication noncompliance was assessed using the Morisky Adherence Scale. Patient satisfaction items were selected from the Patient Satisfaction Questionnaire (PSQ-18). Results: Respondents mean age was 57.5 +/- 9.8 years. Most (87.8%) were male. Nearly one-third of patients (31.0%) were noncompliant. Most reported good health (91.9%). Respondents most often cited out-of-pocket costs as a reason for noncompliance (19.2%). Age, gender, health status, smoking status, and cost were associated with medication noncompliance (P < 0.05). Noncompliance was not associated with elapsed time after the intervention or satisfaction (P > 0.05). Medication noncompliance was positively related to cost (odds ratio [OR]= 2.57, 95% CI = 1.334.97) and inversely related to health status (OR = 0.46, 95% CI = 0.250.85) and age (OR = 0.94, 95% CI = 0.910.97). Conclusion: Medication noncompliance is a multifactorial problem. Strategies reducing the economic burden on patients should improve compliance and, thus, treatment outcomes. These findings further efforts to benchmark performance in Armenia and other post-Soviet countries against western standards and experiences. (J Interven Cardiol 2012;25:469475)
引用
收藏
页码:469 / 475
页数:7
相关论文
共 50 条
  • [1] Improving Medication Communication Following Percutaneous Coronary Intervention
    Kohlmann, Keri Q.
    Ring, Michael T.
    Fink, Angela L.
    CIRCULATION, 2021, 144
  • [2] EVALUATION OF PATIENT-REPORTED OUTCOME AND SATISFACTION FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW
    Almubarak, Muhannad A.
    Alanazi, Sultan Ayed K.
    Alzarea, Nawaf Abdulaziz M.
    Alzarea, Waleed Abdullah A.
    Alkhaldi, Ahmed Hamoud E.
    Aljaddua, Salem Ibrahim S.
    Alruwaili, Fahad Naif M.
    Alruwaili, Sayyaf Falah S.
    Alshaya, Omar Mohammed A.
    Alruwaili, Sultan Farhan O.
    Aldaghmani, Norah Farhan O.
    Aldheli, Yaser Abdulkareem J.
    REVISTA IBEROAMERICANA DE PSICOLOGIA DEL EJERCICIO Y EL DEPORTE, 2024, 19 (05): : 524 - 526
  • [3] Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective
    Pettersen, Trond R.
    Fridlund, Bengt
    Bendz, Bjorn
    Nordrehaug, Jan Erik
    Rotevatn, Svein
    Schjott, Jan
    Norekval, Tone M.
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2018, 88 : 16 - 24
  • [4] Cardiovascular Medication Use Following Percutaneous Coronary Intervention: The Australian Experience
    Cole, Justin A.
    Brennan, Angela L.
    Ajani, Andrew E.
    Yan, Bryan P.
    Duffy, Stephen J.
    Loane, Philippa
    Reid, Christopher M.
    Yudi, Matias B.
    New, Gishel
    Black, Alexander
    Shaw, James
    Clark, David J.
    Andrianopoulos, Nick
    CARDIOVASCULAR THERAPEUTICS, 2014, 32 (02) : 47 - 51
  • [5] The Impact of Patient Adherence to Dual Antiplatelet Medication Following Percutaneous Coronary Intervention on the Occurrence of Adverse Cardiovascular Events
    Mansurova, J. A.
    Orekhov, Andrey
    Zhunuspekova, A. S.
    Kassymova, A. A.
    Karazhanova, L. K.
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 425 - 434
  • [6] Patient-tailored antithrombotic therapy following percutaneous coronary intervention
    van der Sangen, Niels M. R.
    Rozemeijer, Rik
    Yin, Dean R. P. P. Chan Pin
    Valgimigli, Marco
    Windecker, Stephan
    James, Stefan K.
    Buccheri, Sergio
    ten Berg, Jurrien M.
    Henriques, Jose P. S.
    Voskuil, Michiel
    Kikkert, Wouter J.
    EUROPEAN HEART JOURNAL, 2021, 42 (10) : 1038 - +
  • [7] Cardiac rehabiilitation and patient education following primary percutaneous coronary intervention
    Thornley, A.
    Kunadian, B.
    Lister, A.
    Turley, A.
    Moffitt, A.
    Close, J.
    Cave, M.
    Hall, J.
    de Belder, M.
    HEART, 2007, 93 : A28 - A28
  • [8] Thrombocytopenia following Percutaneous Coronary Intervention
    Shenoy, Chetan
    Harjai, Kishore J.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2011, 24 (01) : 15 - 26
  • [9] Chronic Stable Angina: Percutaneous Coronary Intervention or Medication?
    Maragiannis, Dimitrios
    Lazaros, George
    Vavuranakis, Manolis
    Chrysohoou, Christina
    Athanassopoulou, Stavroula
    Patialiakas, Athanassios
    Stefanadis, Christodoulos
    HELLENIC JOURNAL OF CARDIOLOGY, 2011, 52 (03) : 246 - 252
  • [10] Coronary Artery Perforation Following Percutaneous Coronary Intervention
    Lee, Michael S.
    Shamouelian, Albert
    Dahodwala, Mufaddal Q.
    JOURNAL OF INVASIVE CARDIOLOGY, 2016, 28 (03): : 122 - 131